Skip to main content
. 2017 Aug 1;38(38):2879–2887. doi: 10.1093/eurheartj/ehx350

Figure 2.

Figure 2

Left ventricular geometry among patients undergoing transcatheter aortic valve replacement with and without ATTR-CA. P-value comparing patients with ATTR-CA vs. no ATTR-CA. ATTR-CA, transthyretin cardiac amyloidosis.